Application 020378

Type
BLA
Sponsor
EMD SERONO

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001GONAL-FFOLLITROPIN ALFA/BETAINJECTABLE;SUBCUTANEOUS75 IU/VIALNoNo
002GONAL-FFOLLITROPIN ALFA/BETAINJECTABLE;SUBCUTANEOUS150 IU/VIALNoNo
003GONAL-FFOLLITROPIN ALFA/BETAINJECTABLE;SUBCUTANEOUS37.5 IU/VIALNoNo
004GONAL-FFOLLITROPIN ALFA/BETAINJECTABLE;SUBCUTANEOUS1,050 IU/VIALNoNo
005GONAL-FFOLLITROPIN ALFA/BETAINJECTABLE;SUBCUTANEOUS450 IU/VIALNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
44087-9030Gonal-ffollitropin alfaEMD Serono, Inc.BLACurrent
44087-9030Gonal-ffollitropin alfaEMD Serono, Inc.BLACurrent
44087-9030Gonal-ffollitropin alfaEMD Serono, Inc.BLACurrent
44087-9030Gonal-ffollitropin alfaEMD Serono, Inc.NDACurrent
44087-9030Gonal-ffollitropin alfaEMD Serono, Inc.NDACurrent
44087-9030Gonal-ffollitropin alfaEMD Serono, Inc.NDACurrent
44087-9070Gonal-ffollitropin alfaEMD Serono, Inc.BLACurrent
44087-9070Gonal-ffollitropin alfaEMD Serono, Inc.BLACurrent
44087-9070Gonal-ffollitropin alfaEMD Serono, Inc.BLACurrent
44087-9070Gonal-ffollitropin alfaEMD Serono, Inc.NDACurrent
44087-9070Gonal-ffollitropin alfaEMD Serono, Inc.NDACurrent
44087-9070Gonal-ffollitropin alfaEMD Serono, Inc.NDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
76654SUPPL 2023-11-24
76648SUPPL 2023-11-22
65812SUPPL2021-01-04
65811SUPPL2021-01-04
65810SUPPL2021-01-04
65803SUPPL2020-12-31
65802SUPPL2020-12-31
65801SUPPL2020-12-31
62260APPL2020-03-23
41314SUPPL2020-03-23
34573SUPPL2020-03-23
24869SUPPL2020-03-23
24868SUPPL2020-03-23
2423SUPPL2020-03-23
2422SUPPL2020-03-23